Constipation

Disease-a-Month

Volumn 57, Issue 9, 2011, Pages 511-517

  Deepak, Parakkal ^a   Ehrenpreis, Eli D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALUMINUM CHLORIDE; AMIODARONE; ANTACID AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTIPARKINSON AGENT; BILE ACID SEQUESTRANT; BISMUTH SALICYLATE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHLORIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; CLOZAPINE; DICYCLOVERINE; DIURETIC AGENT; FUROSEMIDE; HALOPERIDOL; HYDROCHLOROTHIAZIDE; IRON SALT; LITHIUM; MONOAMINE OXIDASE INHIBITOR; NIFEDIPINE; OPIATE; PHENOTHIAZINE DERIVATIVE; RISPERIDONE; SEROTONIN 3 ANTAGONIST; UNINDEXED DRUG; VERAPAMIL; VINCA ALKALOID;

ADRENERGIC ACTIVITY; ANOREXIA; ARTICLE; BIPOLAR DISORDER; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG MEGADOSE; FECES ANALYSIS; HARD FECES; HUMAN; INTESTINE OBSTRUCTION; LOOSE FECES; NAUSEA; PROPHYLAXIS;

ANTACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIHYPERTENSIVE AGENTS; CHOLINERGIC ANTAGONISTS; CONSTIPATION; HUMANS; PARASYMPATHOLYTICS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80053208666     PISSN: 00115029     EISSN: 15578194     Source Type: Journal    
DOI: 10.1016/j.disamonth.2011.05.006     Document Type: Article

References (33)

1. Longstreth G.F., Thompson W.G., Chey W.D., et al. Functional bowel disorders. Gastroenterology 2006, 130:1480-1491.
2. Talley N.J., Jones M., Nuyts G., et al. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol 2003, 98:1107-1111.
3. Ratnaike R.N., Milton A.G., Nigro O. Drug associated diarrhea and constipation in older people. 2. Constipation. Aust J Hosp Pharmacist 2000, 30:210-213.
4. Toney R.C., Wallace D., Sekhon S., et al. Medication induced constipation and diarrhea. Pract Gastroenterol 2008, 18:12-28.
5. Neitlich J.D., Burrell M.I. Drug-induced disorders of the colon. Abdom Imaging 1999, 24:23-28.
6. Rebecca L.B., Butt T.F. Drug-induced constipation. Adverse Drug React Bull 2009, 257:987-990.
7. Levin T.T., Barrett J., Mendelowitz A. Death from clozapine-induced constipation: case report and literature review. Psychosomatics 2002, 43:71-73.
8. Drew L., Herdson P. Clozapine and constipation: a serious issue. Aust NZ J Psychiatry 1997, 31:149-150.
9. Hayes G., Gibler B. Clozapine-induced constipation. Am J Psychiatry 1995, 152:298.
10. Theret L., Germain M.L., Burde A. Current aspects of the use of clozapine in the Chalonssur-Marne Psychiatric Hospital: intestinal occlusion with clozapine [article in French]. Ann Med Psychol (Paris) 1995, 153:474-477.
11. Shammi C.M., Remington G. Clozapine-induced necrotizing colitis. J Clin Psychopharmacol 1997, 17:230-232.
12. Freudenreich O., Goff D.C. Colon perforation and peritonitis associated with clozapine. J Clin Psychiatry 2000, 61:950-951.
13. Palmer S.E., McLean R.M., Ellis P.M., et al. Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases. J Clin Psychiatry 2008, 69(5):759-768.
14. Lim D.K., Mahendran R. Risperidone and megacolon. Singapore Med J 2002, 43:530-532.
15. Standaert David G., Young Anne B. Chapter 20. Treatment of Central Nervous System Degenerative Disorders In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman's Pharmacological Basis of Therapeutics, 11e. http://www.accessmedicine.com/content.aspx?aID=940432.
16. Grigoleit H.G., Grigoleit P. Pharmacology and preclinical pharmacokinetics of peppermint oil. Phytomedicine 2005, 12:612-616.
17. White W.B., Johnson M.F., Anders R.J., et al. Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease. Am Heart J 2001, 142:1010-1015.
18. Schwartz A., Triggle D.J. Cellular action of calcium channel blocking drugs. Annu Rev Med 1984, 35:325-339.
19. Umezawa T., Guo S., Jiao Y., et al. Effect of clonidine on colonic motility in rats. Auton Neurosci 2003, 107(1):32-36.
20. Maton P.N., Burton M.E. Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use. Drugs 1999, 57:855-870.
21. DuPont H.L., Ericsson C.D. Prevention and treatment of traveler's diarrhea. N Engl J Med 1999, 328:1821-1827.
22. McMillan S.C. Assessing and managing opiate-induced constipation in adults with cancer. Cancer Control 2004, 11(3 Suppl):3-9.
23. De La C.I.M. Insights into opioid action in the intestinal tract. Pharmacol Ther 1996, 69:103-115.
24. Adler H.F. Effect of morphine and Dilaudid on the ileum and of morphine Dilaudid and atropine on the colon of man. Arch Intern Med 1942, 69:974-985.
25. Choi Y.S., Billings J.A. Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation. J Pain Symptom Manage 2002, 24:71-90.
26. Yuan C.S., Foss J.F., O'Connor M., et al. Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial. JAMA 2000, 283(3):367-372.
27. Herranz J.L., Armijo J.A., Arteaga R. Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children. Epilepsia 1988, 29:794-804.
28. Jones R.H., Tait C.L. Gastrointestinal side-effects of NSAIDs in the community. Br J Clin Practice 1995, 49:67-70.
29. Toghill P.J., Burke J.D. Death from paralytic ileus following vincristine therapy. Postgrad Med J 1970, 46:330-331.
30. Johnston C.F., Shaw C., Buchanan K.D. Vincristine-induced abnormalities of gastrointestinal regulatory peptide cells of the rat. An immunocytochemical study. Cell Tissue Res 1985, 239:229-233.
31. Jackson D.V., Wells H.B., Atkins J.N., et al. Amelioration of vincristine neurotoxicity by glutamic acid. Am J Med 1988, 84:1016-1022.
32. Siddoway L.A. Amiodarone: guidelines for use and monitoring. Am Fam Physician 2003, 68:2189-2196.
33. Ast M., Frishman W.H. Bile acid sequestrants. J Clin Pharmacol 1990, 30:99-106.